SmallCaps
ASX:AT1Health Care Equipment & ServicesHealth Care Equipment

Atomo Diagnostics Ltd

$0.018
Day Range
$0.000 – $0.000
52 Week Range
$0.000 – $0.048
Volume
0.00
Avg Volume (10D)
1.01M
Market Cap
$15.79M
Price Chart
Market Statistics
Open$0.018
Previous Close$0.018
Day High$0.000
Day Low$0.000
52 Week High$0.048
0
Valuation
Market Cap15.79M
Shares Outstanding902.43M
Price to Book2.13
Trading Activity
Volume0.00
Value Traded0.00
Bid$0.017 × 447,908
Ask$0.018 × 71,140
Performance
1 Day0.00%
5 Day2.94%
13 Week-27.08%
52 Week-2.78%
YTD-51.39%
Technical Indicators
RSI (14)50.52
50-Day SMA$0.018
200-Day SMA$0.029
Latest News
Atomo Diagnostics to supply HIV test kits across SA and Victoria as part of national vending machine program
Biotechnology

Atomo Diagnostics to supply HIV test kits across SA and Victoria as part of national vending machine program

Atomo Diagnostics (ASX: AT1) has received a $230,000 order from Thorne Harbour Health for HIV Self Test kits to support a national scale-up of the federal government’s CONNECT program, which provides free kits through vending machines. Thorne’s order will supply kits to machines across South Australia and Victoria as part of the government’s pilot program […]

Weekly wrap: WiseTech relief rally helps market to bounce higher
Hot Topics

Weekly wrap: WiseTech relief rally helps market to bounce higher

After days of fairly salacious headlines around WiseTech founder Richard White and his penchant for delivering mansions to girlfriends, the company pushed the entire Australian market into making a small gain. News that Mr White would step aside as chief executive but will return in a full-time product and business development consulting role led to […]

Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test
Biotechnology

Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test

Atomo Diagnostics (ASX: AT1) has again been recognised by the Australian government with the award of a $2.44 million grant to develop a unique syphilis test. The Australian-based medical device company was awarded the CRC-P industry grant from the Department of Industry, Science and Resources (DISR) to support the development of an innovative rapid active […]

Atomo Diagnostics boosted by federal funding for HIV prevention and self-test expansion
Biotechnology

Atomo Diagnostics boosted by federal funding for HIV prevention and self-test expansion

Medical device company Atomo Diagnostics (ASX: AT1) has welcomed the Australian government’s commitment to fund the expansion of self-testing procedures for human immunodeficiency virus (HIV) in this week’s federal budget. The company anticipates that a significant portion of the $43.9 million committed to HIV prevention will be used for the procurement of more of its […]